Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

373 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Standardizing naming conventions in radiation oncology.
Santanam L, Hurkmans C, Mutic S, van Vliet-Vroegindeweij C, Brame S, Straube W, Galvin J, Tripuraneni P, Michalski J, Bosch W. Santanam L, et al. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1344-9. doi: 10.1016/j.ijrobp.2011.09.054. Epub 2012 Jan 13. Int J Radiat Oncol Biol Phys. 2012. PMID: 22245204 Free PMC article.
Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.
Michalski JM, Yan Y, Watkins-Bruner D, Bosch WR, Winter K, Galvin JM, Bahary JP, Morton GC, Parliament MB, Sandler HM. Michalski JM, et al. Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):932-8. doi: 10.1016/j.ijrobp.2013.07.041. Epub 2013 Oct 8. Int J Radiat Oncol Biol Phys. 2013. PMID: 24113055 Free PMC article. Clinical Trial.
Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.
Henke L, Kashani R, Yang D, Zhao T, Green O, Olsen L, Rodriguez V, Wooten HO, Li HH, Hu Y, Bradley J, Robinson C, Parikh P, Michalski J, Mutic S, Olsen JR. Henke L, et al. Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1078-1086. doi: 10.1016/j.ijrobp.2016.08.036. Epub 2016 Aug 31. Int J Radiat Oncol Biol Phys. 2016. PMID: 27742541 Free PMC article.
Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital-based analysis of patterns of care, RT fractionation scheme, and overall survival.
Fischer-Valuck BW, Baumann BC, Apicelli A, Rao YJ, Roach M, Daly M, Dans MC, White P, Contreras J, Henke L, Gay H, Michalski JM, Abraham C. Fischer-Valuck BW, et al. Among authors: michalski jm. Cancer Med. 2018 Sep;7(9):4240-4250. doi: 10.1002/cam4.1655. Epub 2018 Aug 17. Cancer Med. 2018. PMID: 30120817 Free PMC article.
A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer Database.
Fischer-Valuck BW, Michalski JM, Contreras JA, Brenneman R, Christodouleas JP, Abraham CD, Kim EH, Arora VK, Bullock AD, Carmona R, Figenshau RS, Grubb R 3rd, Knoche EM, Pachynski RK, Picus J, Roth BJ, Sargos P, Andriole GL, Gay HA, Baumann BC. Fischer-Valuck BW, et al. Among authors: michalski jm. Clin Transl Radiat Oncol. 2018 Dec 12;15:38-41. doi: 10.1016/j.ctro.2018.12.001. eCollection 2019 Feb. Clin Transl Radiat Oncol. 2018. PMID: 30656221 Free PMC article.
NCTN Assessment on Current Applications of Radiomics in Oncology.
Nie K, Al-Hallaq H, Li XA, Benedict SH, Sohn JW, Moran JM, Fan Y, Huang M, Knopp MV, Michalski JM, Monroe J, Obcemea C, Tsien CI, Solberg T, Wu J, Xia P, Xiao Y, El Naqa I. Nie K, et al. Among authors: michalski jm. Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):302-315. doi: 10.1016/j.ijrobp.2019.01.087. Epub 2019 Jan 31. Int J Radiat Oncol Biol Phys. 2019. PMID: 30711529 Free PMC article. Review.
Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer.
Fischer-Valuck BW, Michalski JM, Mitra N, Christodouleas JP, DeWees TA, Kim E, Smith ZL, Andriole GL, Arora V, Bullock A, Carmona R, Figenshau RS, Grubb RL, Guzzo TJ, Knoche EM, Malkowicz SB, Mamtani R, Pachynski RK, Roth BJ, Zaghloul MS, Gay HA, Baumann BC. Fischer-Valuck BW, et al. Among authors: michalski jm. Cancer Med. 2019 Jul;8(8):3698-3709. doi: 10.1002/cam4.2102. Epub 2019 May 22. Cancer Med. 2019. PMID: 31119885 Free PMC article.
Long-Term Benefits of Dose-Escalation in Localized Prostate Cancer.
Spratt DE, Michalski JM. Spratt DE, et al. Among authors: michalski jm. Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):798-800. doi: 10.1016/j.ijrobp.2019.04.001. Int J Radiat Oncol Biol Phys. 2019. PMID: 31204661 No abstract available.
Management of primary skin cancer during a pandemic: Multidisciplinary recommendations.
Baumann BC, MacArthur KM, Brewer JD, Mendenhall WM, Barker CA, Etzkorn JR, Jellinek NJ, Scott JF, Gay HA, Baumann JC, Manian FA, Devlin PM, Michalski JM, Lee NY, Thorstad WL, Wilson LD, Perez CA, Miller CJ. Baumann BC, et al. Among authors: michalski jm. Cancer. 2020 Sep 1;126(17):3900-3906. doi: 10.1002/cncr.32969. Epub 2020 Jun 1. Cancer. 2020. PMID: 32478867 Free PMC article. Review.
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy.
Fischer-Valuck BW, Michalski JM, Harton JG, Birtle A, Christodouleas JP, Efstathiou JA, Arora VK, Kim EH, Knoche EM, Pachynski RK, Picus J, Rao YJ, Reimers M, Roth BJ, Sargos P, Smith ZL, Zaghloul MS, Gay HA, Patel SA, Baumann BC. Fischer-Valuck BW, et al. Among authors: michalski jm. Clin Genitourin Cancer. 2021 Feb;19(1):41-46.e1. doi: 10.1016/j.clgc.2020.06.005. Epub 2020 Jun 22. Clin Genitourin Cancer. 2021. PMID: 33187904 Free PMC article.
MR-Guided Adaptive Radiotherapy for Bladder Cancer.
Hijab A, Tocco B, Hanson I, Meijer H, Nyborg CJ, Bertelsen AS, Smeenk RJ, Smith G, Michalski J, Baumann BC, Hafeez S. Hijab A, et al. Front Oncol. 2021 Feb 25;11:637591. doi: 10.3389/fonc.2021.637591. eCollection 2021. Front Oncol. 2021. PMID: 33718230 Free PMC article. Review.
Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysis.
Roy A, Brenneman RJ, Hogan J, Barnes JM, Huang Y, Morris R, Goddu S, Altman M, Garcia-Ramirez J, Li H, Zoberi JE, Bullock A, Kim E, Smith Z, Figenshau R, Andriole GL, Baumann BC, Michalski JM, Gay HA. Roy A, et al. Among authors: michalski jm. Clin Transl Radiat Oncol. 2021 May 13;29:47-53. doi: 10.1016/j.ctro.2021.05.004. eCollection 2021 Jul. Clin Transl Radiat Oncol. 2021. PMID: 34136665 Free PMC article.
Feasibility of Same-Day Prostate Fiducial Markers, Perirectal Hydrogel Spacer Placement, and Computed Tomography and Magnetic Resonance Imaging Simulation for External Beam Radiation Therapy for Low-Risk and Intermediate-Risk Prostate Cancer.
Brenneman RJ, Goddu SM, Andruska N, Roy A, Bosch WR, Fischer-Valuck B, Efstathiou JA, Gay HA, Michalski JM, Baumann BC. Brenneman RJ, et al. Among authors: michalski jm. Pract Radiat Oncol. 2022 Mar-Apr;12(2):e117-e122. doi: 10.1016/j.prro.2021.09.015. Epub 2021 Oct 22. Pract Radiat Oncol. 2022. PMID: 34695615 Free PMC article. Clinical Trial.
Technical Report: Development and Implementation of an Open Source Template Interpretation Class Library for Automated Treatment Planning.
Schmidt MC, Pryser EA, Baumann BC, Yaqoub MM, Raman CA, Szentivanyi P, Michalski JM, Gay HA, Knutson NC, Hugo G, Sajo E, Zygmanski P, Mazur T, Dise J, Cammin J, Laugeman E, Reynoso FJ. Schmidt MC, et al. Among authors: michalski jm. Pract Radiat Oncol. 2022 Mar-Apr;12(2):e153-e160. doi: 10.1016/j.prro.2021.11.004. Epub 2021 Nov 25. Pract Radiat Oncol. 2022. PMID: 34839048
Survival Outcomes in Men with Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Prostate-Only versus Whole Pelvic Radiation Therapy.
Andruska N, Fischer-Valuck BW, Waters M, Juarez Diaz E, Agabalogun T, Kim EH, Smith ZL, Brenneman RJ, Gay HA, Andriole GL, Michalski JM, Baumann BC. Andruska N, et al. Among authors: michalski jm. J Urol. 2022 Jun;207(6):1227-1235. doi: 10.1097/JU.0000000000002455. Epub 2022 Jan 27. J Urol. 2022. PMID: 35085038 Free PMC article.
Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancer.
Andruska N, Michalski JM, Carmona R, Agabalogun T, Brenneman RJ, Gay HA, Fischer-Valuck BW, Baumann BC. Andruska N, et al. Among authors: michalski jm. Brachytherapy. 2022 May-Jun;21(3):317-324. doi: 10.1016/j.brachy.2021.12.008. Epub 2022 Feb 3. Brachytherapy. 2022. PMID: 35123889 Free PMC article.
Assessing Inter-Fraction Changes in The Size and Position of The Penile Bulb During Daily MR-Guided Radiation Therapy to The Prostate Bed: Do We Need to Adjust How We Plan Radiation in The Post-Radical Prostatectomy Setting to Reduce Risk of Erectile Dysfunction?
Roy A, Green O, Brenneman R, Bosch W, Gay HA, Michalski JM, Baumann BC. Roy A, et al. Among authors: michalski jm. Clin Genitourin Cancer. 2022 Jun;20(3):e227-e232. doi: 10.1016/j.clgc.2022.01.006. Epub 2022 Jan 11. Clin Genitourin Cancer. 2022. PMID: 35153154 Free PMC article.
Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate Cancer.
Fischer-Valuck BW, Baumann BC, Brown SA, Filson CP, Weiss A, Mueller R, Liu Y, Brenneman RJ, Sanda M, Michalski JM, Gay HA, James Rao Y, Pattaras JG, Jani AB, Hershatter B, Patel SA. Fischer-Valuck BW, et al. Among authors: michalski jm. Eur Urol Open Sci. 2022 Feb 1;37:80-89. doi: 10.1016/j.euros.2021.12.011. eCollection 2022 Mar. Eur Urol Open Sci. 2022. PMID: 35243392 Free PMC article.
Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy.
Fischer-Valuck BW, Patel SA, Brenneman RJ, Christodouleas J, Sargos P, Kim E, Weiss A, Hershatter B, Rao YJ, Picus J, Roth B, Arora V, Carmona R, Reimers M, Zaghloul MS, Gay H, Michalski JM, Baumann BC. Fischer-Valuck BW, et al. Among authors: michalski jm. Eur Urol Oncol. 2022 Apr;5(2):246-250. doi: 10.1016/j.euo.2022.02.001. Epub 2022 Mar 3. Eur Urol Oncol. 2022. PMID: 35249864 Free PMC article.
Reply by Authors.
Andruska N, Fischer-Valuck BW, Waters M, Juarez Diaz E, Agabalogun T, Kim EH, Smith ZL, Brenneman RJ, Gay HA, Andriole GL, Michalski JM, Baumann BC. Andruska N, et al. Among authors: michalski jm. J Urol. 2022 Jun;207(6):1235. doi: 10.1097/JU.0000000000002455.02. Epub 2022 Mar 14. J Urol. 2022. PMID: 35282697 No abstract available.
Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy.
Andruska N, Agabalogun T, Fischer-Valuck BW, Brenneman RJ, Huang Y, Gay HA, Michalski JM, Carmona R, Baumann BC. Andruska N, et al. Among authors: michalski jm. Brachytherapy. 2022 Sep-Oct;21(5):617-625. doi: 10.1016/j.brachy.2022.04.001. Epub 2022 May 28. Brachytherapy. 2022. PMID: 35641370 Free PMC article.
Lutetium-177 DOTATATE: A Practical Review.
Jia AY, Kashani R, Zaorsky NG, Spratt DE, Kiess AP, Michalski JM, Zoberi JE, Kim H, Baumann BC. Jia AY, et al. Among authors: michalski jm. Pract Radiat Oncol. 2022 Jul-Aug;12(4):305-311. doi: 10.1016/j.prro.2022.02.002. Pract Radiat Oncol. 2022. PMID: 35717045 Review.
Logistical, technical, and radiation safety aspects of establishing a radiopharmaceutical therapy program: A case in Lutetium-177 prostate-specific membrane antigen (PSMA) therapy.
Zoberi JE, Garcia-Ramirez J, Luechtefeld D, Maughan NM, Amurao M, Oyama R, Baumann BC, Gay HA, Michalski JM. Zoberi JE, et al. Among authors: michalski jm. J Appl Clin Med Phys. 2023 Apr;24(4):e13899. doi: 10.1002/acm2.13899. Epub 2023 Jan 13. J Appl Clin Med Phys. 2023. PMID: 36637862 Free PMC article.
Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?
Andruska N, Waters MR, Fischer-Valuck BW, Smith ZL, Kim EH, Reimers M, Brenneman R, Gay HA, Patel SA, Michalski JM, Delacroix SE, Efstathiou JA, Baumann BC. Andruska N, et al. Among authors: michalski jm. Clin Genitourin Cancer. 2023 Dec;21(6):653-659.e1. doi: 10.1016/j.clgc.2023.07.011. Epub 2023 Aug 2. Clin Genitourin Cancer. 2023. PMID: 37704483 Clinical Trial.
CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer.
Waters M, Price A, Laugeman E, Henke L, Hugo G, Stowe H, Andruska N, Brenneman R, Hao Y, Green O, Robinson C, Gay H, Michalski J, Baumann BC. Waters M, et al. Clin Transl Radiat Oncol. 2023 Oct 24;44:100693. doi: 10.1016/j.ctro.2023.100693. eCollection 2024 Jan. Clin Transl Radiat Oncol. 2023. PMID: 38021093 Free PMC article.
Tumor and target delineation: current research and future challenges.
Austin-Seymour M, Chen GT, Rosenman J, Michalski J, Lindsley K, Goitein M. Austin-Seymour M, et al. Int J Radiat Oncol Biol Phys. 1995 Dec 1;33(5):1041-52. doi: 10.1016/0360-3016(95)00215-4. Int J Radiat Oncol Biol Phys. 1995. PMID: 7493830
Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.
Myerson RJ, Michalski JM, King ML, Birnbaum E, Fleshman J, Fry R, Kodner I, Lacey D, Lockett MA. Myerson RJ, et al. Among authors: michalski jm. Int J Radiat Oncol Biol Phys. 1995 Apr 30;32(1):41-50. doi: 10.1016/0360-3016(94)00493-5. Int J Radiat Oncol Biol Phys. 1995. PMID: 7721638
373 results